Tumor Biology and Frailty May Guide Selection for Primary Endocrine Therapy in ER-Positive Breast Cancer: JAMA

Coverage, in order

1. 3d ago
   
   Medical Dialogues India obscure meta-analysispeer-reviewedn=22,000

   Tumor Biology and Frailty May Guide Selection for Primary Endocrine Therapy in ER-Positive Breast Cancer: JAMA

   USA: A systematic review and meta-analysis involving over 22,000 patients with ER-positive breast cancer has found no statistically significant difference in survival between primary endocrine therapy (pET) and upfront surgery . Durable disease control with pET appeared more likely in patients with…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.